Back to Journals » OncoTargets and Therapy » Volume 13

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma

Total article views   HTML views PDF downloads Totals
8,567 Dovepress* 6,590+ 1,307 7,897
PubMed Central* 1,977 512 2,489
Totals 8,567 1,819 10,386
*Since 5 February 2020

View citations on PubMed Central and Google Scholar